San Francisco—Resistance to drugs used
in simplified drug regimens designed to prevent or treat HIV infection is
complicating efforts to fight the AIDS epidemic, according to new findings
reported here at the 11th Annual Retrovirus Conference.
In addition, researchers described other work highlighting the importance
of tracking HIV infection in the United States to identify opportunities for
focused prevention efforts.
A drug regimen used in resource-poor countries to prevent mother-to-child
HIV transmission might compromise a mother's response to future treatment
because it may promote drug resistance, according to findings of studies in
South Africa and Thailand.
Stephenson J. Researchers Report Findings on HIV Drug Resistance, New Infections. JAMA. 2004;291(12):1431–1433. doi:10.1001/jama.291.12.1431
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: